Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christof Seidl

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Nuclear Medicine and Biology|November 12, 2013
²¹³Bi-anti-EGFR radioimmunoconjugates and X-ray irradiation trigger different cell death pathways in squamous cell carcinoma cellsAnja Pickhard, Guido Piontek, Christof Seidl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 25, 2007
Development and evaluation of peptidic ligands targeting tumour-associated urokinase plasminogen activator receptor (uPAR) for use in alpha-emitter therapy for disseminated ovarian cancerSebastian Knör, Sumito Sato, Timo Huber, et al.
Frontiers in Oncology|July 26, 2021
Drug Repurposing of Pantoprazole and Vitamin C Targeting Tumor Microenvironment Conditions Improves Anticancer Effect in Metastatic Castration-Resistant Prostate CancerZhoulei Li, Peng He, Yali Long, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Locoregional alpha-radioimmunotherapy of intraperitoneal tumor cell dissemination using a tumor-specific monoclonal antibodyRoswitha Huber, Christof Seidl, Ernst Schmid, et al.
International Journal of Molecular Sciences|December 9, 2023
Comparative Analysis of Morphological and Functional Effects of <sup>225</sup>Ac- and <sup>177</sup>Lu-PSMA Radioligand Therapies (RLTs) on Salivary GlandsBenedikt Feuerecker, Andrei Gafita, Thomas Langbein, et al.
British Journal of Cancer|October 6, 2018
Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancerPing Wang, Viktor Magdolen, Christof Seidl, et al.
Frontiers in Pharmacology|October 19, 2020
Increased Tumoral Microenvironmental pH Improves Cytotoxic Effect of Pharmacologic Ascorbic Acid in Castration-Resistant Prostate Cancer CellsZhoulei Li, Peng He, Ganhua Luo, et al.
Plos One|May 30, 2009
Treatment of peritoneal carcinomatosis by targeted delivery of the radio-labeled tumor homing peptide bi-DTPA-[F3]2 into the nucleus of tumor cellsEnken Drecoll, Florian C Gaertner, Matthias Miederer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 26, 2005
Cell death triggered by alpha-emitting 213Bi-immunoconjugates in HSC45-M2 gastric cancer cells is different from apoptotic cell deathChristof Seidl, Hedwig Schröck, Sabine Seidenschwang, et al.
Radiation Research|April 25, 2003
Comparison of the radiotoxicity of two alpha-particle-emitting immunoconjugates, terbium-149 and bismuth-213, directed against a tumor-specific, exon 9 deleted (d9) E-cadherin adhesion proteinMatthias Miederer, Christof Seidl, Gerd-Jürgen Beyer, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Nuclear Medicine and Biology|November 12, 2013
²¹³Bi-anti-EGFR radioimmunoconjugates and X-ray irradiation trigger different cell death pathways in squamous cell carcinoma cellsAnja Pickhard, Guido Piontek, Christof Seidl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 25, 2007
Development and evaluation of peptidic ligands targeting tumour-associated urokinase plasminogen activator receptor (uPAR) for use in alpha-emitter therapy for disseminated ovarian cancerSebastian Knör, Sumito Sato, Timo Huber, et al.
Frontiers in Oncology|July 26, 2021
Drug Repurposing of Pantoprazole and Vitamin C Targeting Tumor Microenvironment Conditions Improves Anticancer Effect in Metastatic Castration-Resistant Prostate CancerZhoulei Li, Peng He, Yali Long, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Locoregional alpha-radioimmunotherapy of intraperitoneal tumor cell dissemination using a tumor-specific monoclonal antibodyRoswitha Huber, Christof Seidl, Ernst Schmid, et al.
International Journal of Molecular Sciences|December 9, 2023
Comparative Analysis of Morphological and Functional Effects of <sup>225</sup>Ac- and <sup>177</sup>Lu-PSMA Radioligand Therapies (RLTs) on Salivary GlandsBenedikt Feuerecker, Andrei Gafita, Thomas Langbein, et al.
British Journal of Cancer|October 6, 2018
Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancerPing Wang, Viktor Magdolen, Christof Seidl, et al.
Frontiers in Pharmacology|October 19, 2020
Increased Tumoral Microenvironmental pH Improves Cytotoxic Effect of Pharmacologic Ascorbic Acid in Castration-Resistant Prostate Cancer CellsZhoulei Li, Peng He, Ganhua Luo, et al.
Plos One|May 30, 2009
Treatment of peritoneal carcinomatosis by targeted delivery of the radio-labeled tumor homing peptide bi-DTPA-[F3]2 into the nucleus of tumor cellsEnken Drecoll, Florian C Gaertner, Matthias Miederer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 26, 2005
Cell death triggered by alpha-emitting 213Bi-immunoconjugates in HSC45-M2 gastric cancer cells is different from apoptotic cell deathChristof Seidl, Hedwig Schröck, Sabine Seidenschwang, et al.
Radiation Research|April 25, 2003
Comparison of the radiotoxicity of two alpha-particle-emitting immunoconjugates, terbium-149 and bismuth-213, directed against a tumor-specific, exon 9 deleted (d9) E-cadherin adhesion proteinMatthias Miederer, Christof Seidl, Gerd-Jürgen Beyer, et al.
Pageof 5